APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Activin and Inhibin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Activin and Inhibin Industry Growth and Trends Forecast to 2032

Report ID 173960190120 December 2025103 pages

Choose your research edition.

Industry ResearchActivin and Inhibin Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Activin and Inhibin Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Activin and Inhibin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Activin and Inhibin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Activin and Inhibin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Activin and Inhibin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Activin and Inhibin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Activin and Inhibin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Activin and Inhibin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Activin and Inhibin include Thermo Fisher Scientific, StemRD, STEMCELL, Sino Biological, ReproCELL, Proteintech Group, Prospec, PeproTech and Merck Millipore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Activin and Inhibin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Activin and Inhibin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Activin and Inhibin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Activin and Inhibin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Activin and Inhibin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Activin and Inhibin Market by Company

Thermo Fisher Scientific

StemRD

STEMCELL

Sino Biological

ReproCELL

Proteintech Group

Prospec

PeproTech

Merck Millipore

IBL

Enzo Life Sciences

Bio-Techne

Ajinomoto

Activin and Inhibin Segment by Type

Activin

Inhibin

Activin and Inhibin Segment by Application

Commercial Research

Academic Research

Activin and Inhibin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Activin and Inhibin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Activin and Inhibin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Activin and Inhibin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Activin and Inhibin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Activin and Inhibin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Activin Table 2. Major Company of Inhibin Table 3. Global Activin and Inhibin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Activin and Inhibin Sales by Type (2021-2026) & (k units) Table 5. Global Activin and Inhibin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Activin and Inhibin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Activin and Inhibin Sales Market Share in Value by Type (2021-2026) Table 8. Global Activin and Inhibin Price by Type (2021-2026) & (US$/unit) Table 9. Global Activin and Inhibin Sales by Type (2027-2032) & (k units) Table 10. Global Activin and Inhibin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Activin and Inhibin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Activin and Inhibin Sales Market Share in Value by Type (2027-2032) Table 13. Global Activin and Inhibin Price by Type (2027-2032) & (US$/unit) Table 14. North America Activin and Inhibin Sales by Type (2021-2026) & (k units) Table 15. North America Activin and Inhibin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Activin and Inhibin Sales by Type (2021-2026) & (k units) Table 17. Europe Activin and Inhibin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Activin and Inhibin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Activin and Inhibin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Activin and Inhibin Sales by Type (2021-2026) & (k units) Table 21. Latin America Activin and Inhibin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Activin and Inhibin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Activin and Inhibin Sales by Type (2021-2026) & (US$ Million) Table 24. Activin and Inhibin Industry Trends Table 25. Activin and Inhibin Industry Drivers Table 26. Activin and Inhibin Industry Opportunities and Challenges Table 27. Activin and Inhibin Industry Restraints Table 28. Global Activin and Inhibin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Activin and Inhibin Revenue Market Share by Company (2021-2026) Table 30. Global Activin and Inhibin Sales by Company (2021-2026) & (k units) Table 31. Global Activin and Inhibin Sales Share by Company (2021-2026) Table 32. Global Activin and Inhibin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Activin and Inhibin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Activin and Inhibin Major Company Production Sites and Headquarters Table 35. Global Activin and Inhibin Company, Product Type & Application Table 36. Global Activin and Inhibin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Activin and Inhibin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Activin and Inhibin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Activin and Inhibin Sales by Region (2021-2026) & (k units) Table 41. Global Activin and Inhibin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Activin and Inhibin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Activin and Inhibin Sales Market Share in Value by Region (2021-2026) Table 44. Global Activin and Inhibin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Activin and Inhibin Sales by Region (2027-2032) & (k units) Table 46. Global Activin and Inhibin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Activin and Inhibin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Activin and Inhibin Sales Market Share in Value by Region (2027-2032) Table 49. Global Activin and Inhibin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Activin and Inhibin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Activin and Inhibin Sales by Application (2021-2026) & (k units) Table 52. Global Activin and Inhibin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Activin and Inhibin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Activin and Inhibin Sales Market Share in Value by Application (2021-2026) Table 55. Global Activin and Inhibin Price by Application (2021-2026) & (US$/unit) Table 56. Global Activin and Inhibin Sales by Application (2027-2032) & (k units) Table 57. Global Activin and Inhibin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Activin and Inhibin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Activin and Inhibin Sales Market Share in Value by Application (2027-2032) Table 60. Global Activin and Inhibin Price by Application (2027-2032) & (US$/unit) Table 61. North America Activin and Inhibin Sales by Application (2021-2026) & (k units) Table 62. North America Activin and Inhibin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Activin and Inhibin Sales by Application (2021-2026) & (k units) Table 64. Europe Activin and Inhibin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Activin and Inhibin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Activin and Inhibin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Activin and Inhibin Sales by Application (2021-2026) & (k units) Table 68. Latin America Activin and Inhibin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Activin and Inhibin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Activin and Inhibin Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Activin and Inhibin Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. StemRD Company Information Table 77. StemRD Business Overview Table 78. StemRD Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. StemRD Activin and Inhibin Product Portfolio Table 80. StemRD Recent Development Table 81. STEMCELL Company Information Table 82. STEMCELL Business Overview Table 83. STEMCELL Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. STEMCELL Activin and Inhibin Product Portfolio Table 85. STEMCELL Recent Development Table 86. Sino Biological Company Information Table 87. Sino Biological Business Overview Table 88. Sino Biological Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Sino Biological Activin and Inhibin Product Portfolio Table 90. Sino Biological Recent Development Table 91. ReproCELL Company Information Table 92. ReproCELL Business Overview Table 93. ReproCELL Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. ReproCELL Activin and Inhibin Product Portfolio Table 95. ReproCELL Recent Development Table 96. Proteintech Group Company Information Table 97. Proteintech Group Business Overview Table 98. Proteintech Group Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Proteintech Group Activin and Inhibin Product Portfolio Table 100. Proteintech Group Recent Development Table 101. Prospec Company Information Table 102. Prospec Business Overview Table 103. Prospec Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Prospec Activin and Inhibin Product Portfolio Table 105. Prospec Recent Development Table 106. PeproTech Company Information Table 107. PeproTech Business Overview Table 108. PeproTech Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. PeproTech Activin and Inhibin Product Portfolio Table 110. PeproTech Recent Development Table 111. Merck Millipore Company Information Table 112. Merck Millipore Business Overview Table 113. Merck Millipore Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Merck Millipore Activin and Inhibin Product Portfolio Table 115. Merck Millipore Recent Development Table 116. IBL Company Information Table 117. IBL Business Overview Table 118. IBL Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. IBL Activin and Inhibin Product Portfolio Table 120. IBL Recent Development Table 121. Enzo Life Sciences Company Information Table 122. Enzo Life Sciences Business Overview Table 123. Enzo Life Sciences Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Enzo Life Sciences Activin and Inhibin Product Portfolio Table 125. Enzo Life Sciences Recent Development Table 126. Bio-Techne Company Information Table 127. Bio-Techne Business Overview Table 128. Bio-Techne Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Bio-Techne Activin and Inhibin Product Portfolio Table 130. Bio-Techne Recent Development Table 131. Ajinomoto Company Information Table 132. Ajinomoto Business Overview Table 133. Ajinomoto Activin and Inhibin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Ajinomoto Activin and Inhibin Product Portfolio Table 135. Ajinomoto Recent Development Table 136. North America Activin and Inhibin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Activin and Inhibin Sales by Country (2021-2026) & (k units) Table 138. North America Activin and Inhibin Sales Market Share by Country (2021-2026) Table 139. North America Activin and Inhibin Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Activin and Inhibin Sales Market Share Forecast by Country (2027-2032) Table 141. North America Activin and Inhibin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Activin and Inhibin Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Activin and Inhibin Market Share by Country (2021-2026) Table 144. North America Activin and Inhibin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Activin and Inhibin Market Share Forecast by Country (2027-2032) Table 146. Europe Activin and Inhibin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Activin and Inhibin Sales by Country (2021-2026) & (k units) Table 148. Europe Activin and Inhibin Sales Market Share by Country (2021-2026) Table 149. Europe Activin and Inhibin Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Activin and Inhibin Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Activin and Inhibin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Activin and Inhibin Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Activin and Inhibin Market Share by Country (2021-2026) Table 154. Europe Activin and Inhibin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Activin and Inhibin Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Activin and Inhibin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Activin and Inhibin Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Activin and Inhibin Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Activin and Inhibin Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Activin and Inhibin Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Activin and Inhibin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Activin and Inhibin Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Activin and Inhibin Market Share by Country (2021-2026) Table 164. Asia-Pacific Activin and Inhibin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Activin and Inhibin Market Share Forecast by Country (2027-2032) Table 166. Latin America Activin and Inhibin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Activin and Inhibin Sales by Country (2021-2026) & (k units) Table 168. Latin America Activin and Inhibin Sales Market Share by Country (2021-2026) Table 169. Latin America Activin and Inhibin Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Activin and Inhibin Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Activin and Inhibin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Activin and Inhibin Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Activin and Inhibin Market Share by Country (2021-2026) Table 174. Latin America Activin and Inhibin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Activin and Inhibin Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Activin and Inhibin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Activin and Inhibin Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Activin and Inhibin Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Activin and Inhibin Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Activin and Inhibin Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Activin and Inhibin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Activin and Inhibin Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Activin and Inhibin Market Share by Country (2021-2026) Table 184. Middle East and Africa Activin and Inhibin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Activin and Inhibin Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Activin and Inhibin Distributors List Table 189. Activin and Inhibin Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Activin and Inhibin Image Figure 2. Global Activin and Inhibin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Activin and Inhibin Market Size (2021-2032) & (US$ Million) Figure 4. Global Activin and Inhibin Sales (2021-2032) & (k units) Figure 5. Activin Image Figure 6. Global Activin Sales YoY Growth (2021-2032) & (k units) Figure 7. Inhibin Image Figure 8. Global Inhibin Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Activin and Inhibin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Activin and Inhibin Market Share by Type 2025 VS 2032 Figure 11. North America Activin and Inhibin Sales Market Share in Volume by Type in 2025 Figure 12. North America Activin and Inhibin Sales Market Share in Value by Type in 2025 Figure 13. Europe Activin and Inhibin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Activin and Inhibin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Activin and Inhibin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Activin and Inhibin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Activin and Inhibin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Activin and Inhibin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Activin and Inhibin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Activin and Inhibin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Activin and Inhibin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Commercial Research Image Figure 24. Global Commercial Research Sales YoY Growth (2021-2032) & (k units) Figure 25. Academic Research Image Figure 26. Global Academic Research Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Activin and Inhibin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Activin and Inhibin Market Share by Application 2025 VS 2032 Figure 29. North America Activin and Inhibin Sales Market Share in Volume by Application in 2025 Figure 30. North America Activin and Inhibin Sales Market Share in Value by Application in 2025 Figure 31. Europe Activin and Inhibin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Activin and Inhibin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Activin and Inhibin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Activin and Inhibin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Activin and Inhibin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Activin and Inhibin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Activin and Inhibin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Activin and Inhibin Sales Market Share in Value by Application in 2025 Figure 39. North America Activin and Inhibin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Activin and Inhibin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Activin and Inhibin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Activin and Inhibin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Activin and Inhibin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Activin and Inhibin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Activin and Inhibin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Activin and Inhibin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Activin and Inhibin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Activin and Inhibin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Activin and Inhibin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Activin and Inhibin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Activin and Inhibin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Activin and Inhibin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Activin and Inhibin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Activin and Inhibin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Activin and Inhibin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Activin and Inhibin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Activin
  • Inhibin
Applications
  • Commercial Research
  • Academic Research
Companies covered
  • Thermo Fisher Scientific
  • StemRD
  • STEMCELL
  • Sino Biological
  • ReproCELL
  • Proteintech Group
  • Prospec
  • PeproTech
  • Merck Millipore
  • IBL
  • Enzo Life Sciences
  • Bio-Techne
  • Ajinomoto

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Activin and Inhibin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Activin and Inhibin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Activin and Inhibin Market by Type
  6. 1.3.1 Activin
  7. 1.3.2 Inhibin
  8. 1.4 Global Activin and Inhibin Market Size by Type
  9. 1.4.1 Global Activin and Inhibin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Activin and Inhibin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Activin and Inhibin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Activin and Inhibin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Activin and Inhibin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Activin and Inhibin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Activin and Inhibin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Activin and Inhibin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Activin and Inhibin Industry Trends
  2. 2.2 Activin and Inhibin Industry Drivers
  3. 2.3 Activin and Inhibin Industry Opportunities and Challenges
  4. 2.4 Activin and Inhibin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Activin and Inhibin Revenue (2021-2026)
  2. 3.2 Global Top Players by Activin and Inhibin Sales (2021-2026)
  3. 3.3 Global Top Players by Activin and Inhibin Price (2021-2026)
  4. 3.4 Global Activin and Inhibin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Activin and Inhibin Major Company Production Sites & Headquarters
  6. 3.6 Global Activin and Inhibin Company, Product Type & Application
  7. 3.7 Global Activin and Inhibin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Activin and Inhibin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Activin and Inhibin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Activin and Inhibin Tier 1, Tier 2, and Tier 3
4 Activin and Inhibin Regional Status and Outlook
  1. 4.1 Global Activin and Inhibin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Activin and Inhibin Historic Market Size by Region
  3. 4.2.1 Global Activin and Inhibin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Activin and Inhibin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Activin and Inhibin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Activin and Inhibin Forecasted Market Size by Region
  7. 4.3.1 Global Activin and Inhibin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Activin and Inhibin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Activin and Inhibin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Activin and Inhibin by Application
  1. 5.1 Activin and Inhibin Market by Application
  2. 5.1.1 Commercial Research
  3. 5.1.2 Academic Research
  4. 5.2 Global Activin and Inhibin Market Size by Application
  5. 5.2.1 Global Activin and Inhibin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Activin and Inhibin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Activin and Inhibin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Activin and Inhibin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Activin and Inhibin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Activin and Inhibin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Activin and Inhibin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Activin and Inhibin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Activin and Inhibin Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 StemRD
  8. 6.2.1 StemRD Company Information
  9. 6.2.2 StemRD Business Overview
  10. 6.2.3 StemRD Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 StemRD Activin and Inhibin Product Portfolio
  12. 6.2.5 StemRD Recent Developments
  13. 6.3 STEMCELL
  14. 6.3.1 STEMCELL Company Information
  15. 6.3.2 STEMCELL Business Overview
  16. 6.3.3 STEMCELL Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 STEMCELL Activin and Inhibin Product Portfolio
  18. 6.3.5 STEMCELL Recent Developments
  19. 6.4 Sino Biological
  20. 6.4.1 Sino Biological Company Information
  21. 6.4.2 Sino Biological Business Overview
  22. 6.4.3 Sino Biological Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sino Biological Activin and Inhibin Product Portfolio
  24. 6.4.5 Sino Biological Recent Developments
  25. 6.5 ReproCELL
  26. 6.5.1 ReproCELL Company Information
  27. 6.5.2 ReproCELL Business Overview
  28. 6.5.3 ReproCELL Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ReproCELL Activin and Inhibin Product Portfolio
  30. 6.5.5 ReproCELL Recent Developments
  31. 6.6 Proteintech Group
  32. 6.6.1 Proteintech Group Company Information
  33. 6.6.2 Proteintech Group Business Overview
  34. 6.6.3 Proteintech Group Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Proteintech Group Activin and Inhibin Product Portfolio
  36. 6.6.5 Proteintech Group Recent Developments
  37. 6.7 Prospec
  38. 6.7.1 Prospec Company Information
  39. 6.7.2 Prospec Business Overview
  40. 6.7.3 Prospec Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Prospec Activin and Inhibin Product Portfolio
  42. 6.7.5 Prospec Recent Developments
  43. 6.8 PeproTech
  44. 6.8.1 PeproTech Company Information
  45. 6.8.2 PeproTech Business Overview
  46. 6.8.3 PeproTech Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PeproTech Activin and Inhibin Product Portfolio
  48. 6.8.5 PeproTech Recent Developments
  49. 6.9 Merck Millipore
  50. 6.9.1 Merck Millipore Company Information
  51. 6.9.2 Merck Millipore Business Overview
  52. 6.9.3 Merck Millipore Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Millipore Activin and Inhibin Product Portfolio
  54. 6.9.5 Merck Millipore Recent Developments
  55. 6.10 IBL
  56. 6.10.1 IBL Company Information
  57. 6.10.2 IBL Business Overview
  58. 6.10.3 IBL Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 IBL Activin and Inhibin Product Portfolio
  60. 6.10.5 IBL Recent Developments
  61. 6.11 Enzo Life Sciences
  62. 6.11.1 Enzo Life Sciences Company Information
  63. 6.11.2 Enzo Life Sciences Business Overview
  64. 6.11.3 Enzo Life Sciences Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Enzo Life Sciences Activin and Inhibin Product Portfolio
  66. 6.11.5 Enzo Life Sciences Recent Developments
  67. 6.12 Bio-Techne
  68. 6.12.1 Bio-Techne Company Information
  69. 6.12.2 Bio-Techne Business Overview
  70. 6.12.3 Bio-Techne Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bio-Techne Activin and Inhibin Product Portfolio
  72. 6.12.5 Bio-Techne Recent Developments
  73. 6.13 Ajinomoto
  74. 6.13.1 Ajinomoto Company Information
  75. 6.13.2 Ajinomoto Business Overview
  76. 6.13.3 Ajinomoto Activin and Inhibin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ajinomoto Activin and Inhibin Product Portfolio
  78. 6.13.5 Ajinomoto Recent Developments
7 North America by Country
  1. 7.1 North America Activin and Inhibin Sales by Country
  2. 7.1.1 North America Activin and Inhibin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Activin and Inhibin Sales by Country (2021-2026)
  4. 7.1.3 North America Activin and Inhibin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Activin and Inhibin Market Size by Country
  6. 7.2.1 North America Activin and Inhibin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Activin and Inhibin Market Size by Country (2021-2026)
  8. 7.2.3 North America Activin and Inhibin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Activin and Inhibin Sales by Country
  2. 8.1.1 Europe Activin and Inhibin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Activin and Inhibin Sales by Country (2021-2026)
  4. 8.1.3 Europe Activin and Inhibin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Activin and Inhibin Market Size by Country
  6. 8.2.1 Europe Activin and Inhibin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Activin and Inhibin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Activin and Inhibin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Activin and Inhibin Sales by Country
  2. 9.1.1 Asia-Pacific Activin and Inhibin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Activin and Inhibin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Activin and Inhibin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Activin and Inhibin Market Size by Country
  6. 9.2.1 Asia-Pacific Activin and Inhibin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Activin and Inhibin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Activin and Inhibin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Activin and Inhibin Sales by Country
  2. 10.1.1 South America Activin and Inhibin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Activin and Inhibin Sales by Country (2021-2026)
  4. 10.1.3 South America Activin and Inhibin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Activin and Inhibin Market Size by Country
  6. 10.2.1 South America Activin and Inhibin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Activin and Inhibin Market Size by Country (2021-2026)
  8. 10.2.3 South America Activin and Inhibin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Activin and Inhibin Sales by Country
  2. 11.1.1 Middle East and Africa Activin and Inhibin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Activin and Inhibin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Activin and Inhibin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Activin and Inhibin Market Size by Country
  6. 11.2.1 Middle East and Africa Activin and Inhibin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Activin and Inhibin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Activin and Inhibin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Activin and Inhibin Value Chain Analysis
  2. 12.1.1 Activin and Inhibin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Activin and Inhibin Production Mode & Process
  7. 12.2 Activin and Inhibin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Activin and Inhibin Distributors
  10. 12.2.3 Activin and Inhibin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst